Concepedia
Statistics
Publications
31
Citations
3.7K
H-Index
24
Active since
2008
Affiliations
University of California, Los Angeles(Current)
University of California, Davis
University of California, San Francisco
UC Davis Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Julie Dang is an author at University of California, Los Angeles specializing in medicine, tumor biology, and cell biology.
Top concepts
MedicineCell BiologyTumor BiologyGliomaPharmacologyPublic HealthTumor MicroenvironmentCell SignalingNeuro-oncologyEpidemiology
Publications per year
2008–2024
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu et al. · PLoS Medicine · 2008 · 585 citations · Full text
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway
Deliang Guo, Felicia Reinitz, Mary Youssef et al. · Cancer Discovery · 2011 · 435 citations · Full text
Chemoprevention Strategy, Cell Death, Gbm Cell Lines +16
Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
Igor Vivanco, H. Ian Robins, Daniel Rohle et al. · Cancer Discovery · 2012 · 336 citations · Full text
EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
Deliang Guo, Robert M. Prins, Julie Dang et al. · Science Signaling · 2009 · 335 citations · Full text
Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 278 citations · Full text
1–5 of 31